Trial intelligence / Profile preview

Conditioning of insulin responses with intranasal insulin in type 2 diabetes

NL-OMON49422Completed

Sponsor
Leiden University
Start
May 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of human insulin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Leiden University. Primary endpoints: Blood insulin levels during evocation day and Blood glucose levels during evocation day. Started May 2019; status: completed.

02

Drugs

human insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NL-OMON49422.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49422.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call